Medpace Holdings's basic earnings per share (Basic EPS) for the
three
months ended in Mar. 2024 was $3.32.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was $10.17.
Medpace Holdings's EPS (Diluted) for the
three
months ended in Mar. 2024 was $3.20.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $9.81.
Medpace Holdings's EPS without NRI for the
three
months ended in Mar. 2024 was $3.20.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 9.81.
During the past 12 months, Medpace Holdings's average EPS without NRIGrowth Rate was 24.20% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 32.60% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 35.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 11 years, Medpace Holdings's highest 3-Year average EPS without NRI Growth Rate was 68.50% per year. The lowest was -7.80% per year. And the median was 36.55% per year.
Medpace Holdings EPS (Basic) Historical Data
The historical data trend for Medpace Holdings's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Medpace Holdings's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.17
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Medpace Holdings EPS (Basic) Related Terms
Thank you for viewing the detailed overview of Medpace Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Medpace Holdings (Medpace Holdings) Business Description
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEDP has been successfully added to your 